A Phase II Single-arm Clinical Trial of Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Capecitabine (Primary) ; Carboplatin (Primary) ; Eribulin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary) ; Pyrotinib (Primary) ; Trastuzumab (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Dec 2020 New trial record